Literature DB >> 7973549

[Sulfadiazine nephrolithiasis and nephropathy].

H Furrer1, J von Overbeck, P Jaeger, B Hess.   

Abstract

Sulfadiazine-nephropathy and -nephrolithiasis were well known complications of high dose sulfadiazine therapy 50 years ago. In the last few years high dose sulfadiazine therapy has been widely used for treatment of toxoplasmic encephalitis in AIDS patients. As a consequence sulfadiazine-nephropathy and -nephrolithiasis have become increasingly common. We describe 2 patients with the typical picture of these complications. Therapy is based on the fact that the solubility of sulfadiazine and its acetylated metabolite are markedly improved at higher urine-pH levels. Urine alkalinization is also effective for prophylaxis during sulfadiazine treatment. We present our guidelines for prophylaxis and treatment of these complications.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7973549

Source DB:  PubMed          Journal:  Schweiz Med Wochenschr        ISSN: 0036-7672


  2 in total

Review 1.  Sulfadiazine-induced nephrolithiasis in children.

Authors:  Charlotte Catalano-Pons; Sophie Bargy; Deborah Schlecht; Marie-Dominique Tabone; George Deschênes; Albert Bensman; Tim Ulinski
Journal:  Pediatr Nephrol       Date:  2004-06-17       Impact factor: 3.714

Review 2.  Drug-induced renal calculi: epidemiology, prevention and management.

Authors:  Michel Daudon; Paul Jungers
Journal:  Drugs       Date:  2004       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.